Video

What's New for 2024: Dr. Nicole Verdun Offers a Look Inside The Office Of Therapeutic Products

In this first segment of the Cell & Gene Live, 2024 Regulatory Outlook with Dr. Peter Marks and Dr. Nicole Verdun, Dr. Verdun explains the Office of Therapeutic Products, the new super office, which is the result of a reorganization of CBER’s Office of Tissues and Advanced Therapies. She explains what’s on the Office of Therapeutic Products’ regulatory agenda for 2024.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Thermo Fisher Scientific Bioproduction